Skip to main content
Erschienen in: Familial Cancer 3/2021

19.11.2020 | Short Communication

Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes

verfasst von: Francesca Gensini, Roberta Sestini, Alessandro De Luca, Valentina Pinna, Paola Daniele, Lorenzo Orzalesi, Maria Cristina Petrella, Berardino Porfirio, Laura Papi

Erschienen in: Familial Cancer | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

We present a 24-year-old female patient affected by neurofibromatosis type 1 (NF1) who developed a malignant phyllodes tumor of the breast. The molecular studies showed that the patient carried a heterozygous inactivating deleterious variant in BRCA1 inherited from the father associated with a germline de novo pathogenic alteration in NF1; the tumor presented a biallelic inactivation of both genes. Therefore, tumor analyses helped to establish that the germline NF1 and BRCA1 variants were in cis on the paternal chromosome. This last information is important to provide adequate genetic counselling regarding the risk of recurrence in the offspring, as well as opportunity for early intervention. In conclusion, we present the first case of a malignant phyllodes tumor of the breast in patient carrying pathogenic variants in NF1 and BRCA1. Further studies will be necessary to understand if the phyllodes histotype represents a very rare component of NF1-associated breast cancer.
Literatur
1.
Zurück zum Zitat Cimino PJ, Gutmann DH (2018) Neurofibromatosis type 1. Handb Clin Neurol 148:799–811CrossRef Cimino PJ, Gutmann DH (2018) Neurofibromatosis type 1. Handb Clin Neurol 148:799–811CrossRef
2.
Zurück zum Zitat Frayling IM, Mautner VF, van Minkelen R et al (2019) Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation. J Med Genet 56:209–219CrossRef Frayling IM, Mautner VF, van Minkelen R et al (2019) Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation. J Med Genet 56:209–219CrossRef
3.
Zurück zum Zitat El-Zawahry MD, Farid M, Abd el-Latif A, Horeia H, el-Gindy M, Twakal G, el-Zawahry MD et al (1989) Breast lesions in generalized neurofibromatosis: breast cancer and cystosarcoma phylloides. Neurofibromatosis 2:121–124PubMed El-Zawahry MD, Farid M, Abd el-Latif A, Horeia H, el-Gindy M, Twakal G, el-Zawahry MD et al (1989) Breast lesions in generalized neurofibromatosis: breast cancer and cystosarcoma phylloides. Neurofibromatosis 2:121–124PubMed
4.
Zurück zum Zitat Coffin CM, Cassity J, Viskochil D, Randall RL, Albritton K (2004) Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Genet A 127A:40–43CrossRef Coffin CM, Cassity J, Viskochil D, Randall RL, Albritton K (2004) Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Genet A 127A:40–43CrossRef
5.
Zurück zum Zitat Paul A, Paul S (2014) The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) 9:605–618CrossRef Paul A, Paul S (2014) The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) 9:605–618CrossRef
6.
Zurück zum Zitat Campos B, Balmaña J, Gardenyes J, Valenzuela I, Abad O, Fàbregas P, Volpini V, Díez O (2013) Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer. Breast Cancer Res Treat 139:597–602CrossRef Campos B, Balmaña J, Gardenyes J, Valenzuela I, Abad O, Fàbregas P, Volpini V, Díez O (2013) Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer. Breast Cancer Res Treat 139:597–602CrossRef
7.
Zurück zum Zitat Jeon YW, Kim RM, Lim ST, Choi HJ, Suh YJ (2015) Early-onset breast cancer in a family with neurofibromatosis Type 1 associated with a germline mutation in BRCA1. J Breast Cancer 18:97–100CrossRef Jeon YW, Kim RM, Lim ST, Choi HJ, Suh YJ (2015) Early-onset breast cancer in a family with neurofibromatosis Type 1 associated with a germline mutation in BRCA1. J Breast Cancer 18:97–100CrossRef
8.
Zurück zum Zitat Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D’Amico F, Greggi S, Scambia G (2002) BRCA1-related malignancies in a family presenting with von Recklinghausen’s disease. Gynecol Oncol 86:375–378CrossRef Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D’Amico F, Greggi S, Scambia G (2002) BRCA1-related malignancies in a family presenting with von Recklinghausen’s disease. Gynecol Oncol 86:375–378CrossRef
9.
Zurück zum Zitat Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44:481–484CrossRef Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44:481–484CrossRef
10.
Zurück zum Zitat Molina-Montes E, Pérez-Nevot B, Pollán M, Sánchez-Cantalejo E, Espín J, Sánchez MJ (2014) Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: a systematic review and meta-analysis. Breast 23:721–742CrossRef Molina-Montes E, Pérez-Nevot B, Pollán M, Sánchez-Cantalejo E, Espín J, Sánchez MJ (2014) Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: a systematic review and meta-analysis. Breast 23:721–742CrossRef
11.
Zurück zum Zitat Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, BRCA1 and BRCA2 Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416CrossRef Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, BRCA1 and BRCA2 Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416CrossRef
12.
Zurück zum Zitat Khan SA, Badve S (2001) Phyllodes tumors of the breast. Curr Treat Options Oncol 2:139–147CrossRef Khan SA, Badve S (2001) Phyllodes tumors of the breast. Curr Treat Options Oncol 2:139–147CrossRef
13.
Zurück zum Zitat Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628CrossRef Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628CrossRef
14.
Zurück zum Zitat Rhiem K, Flucke U, Engel C, Wappenschmidt B, Reinecke-Lüthge A, Büttner R, Schmutzler RK (2007) Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast. Cancer Genet Cytogenet 176:76–79CrossRef Rhiem K, Flucke U, Engel C, Wappenschmidt B, Reinecke-Lüthge A, Büttner R, Schmutzler RK (2007) Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast. Cancer Genet Cytogenet 176:76–79CrossRef
15.
Zurück zum Zitat Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW (2020) Germline genetic mutations in a multi-center contemporary cohort of 550 phyllodes tumors: an opportunity for expanded multi-gene panel testing. Ann Surg Oncol 27:3633–3640CrossRef Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, Jakub JW (2020) Germline genetic mutations in a multi-center contemporary cohort of 550 phyllodes tumors: an opportunity for expanded multi-gene panel testing. Ann Surg Oncol 27:3633–3640CrossRef
16.
Zurück zum Zitat Yeong J, Thike AA, Young Ng CC, Md Nasir ND, Loh K, Teh BT, Tan PH (2017) A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma. Pathology 49:786–789CrossRef Yeong J, Thike AA, Young Ng CC, Md Nasir ND, Loh K, Teh BT, Tan PH (2017) A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma. Pathology 49:786–789CrossRef
17.
Zurück zum Zitat Nozad S, Sheehan CE, Gay LM, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Schrock AB, Hirshfield KM, Ali N, Ganesan S, Ali SM, Miller VA, Stephens PJ, Ross JS, Chung JH (2017) Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Breast Cancer Res Treat 162:597–602CrossRef Nozad S, Sheehan CE, Gay LM, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Schrock AB, Hirshfield KM, Ali N, Ganesan S, Ali SM, Miller VA, Stephens PJ, Ross JS, Chung JH (2017) Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Breast Cancer Res Treat 162:597–602CrossRef
18.
Zurück zum Zitat Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112:1546–1548CrossRef Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112:1546–1548CrossRef
Metadaten
Titel
Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes
verfasst von
Francesca Gensini
Roberta Sestini
Alessandro De Luca
Valentina Pinna
Paola Daniele
Lorenzo Orzalesi
Maria Cristina Petrella
Berardino Porfirio
Laura Papi
Publikationsdatum
19.11.2020
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 3/2021
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00217-x

Weitere Artikel der Ausgabe 3/2021

Familial Cancer 3/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.